Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial

Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial

Background: Western lifestyle has been associated with an increase in relapsing–remitting multiple sclerosis (RRMS). In mice, dietary wheat amylase–trypsin inhibitors (ATIs) activate intestinal myeloid cells and augment T cell-mediated systemic inflammation. Objective: The aim of this study was to a...

Full description

Bibliographic Details
Main Authors:	Sinah Engel, Luisa Klotz, Timo Wirth, Ann-Katrin Fleck, Geethanjali Pickert, Melanie Eschborn, Samia Kreuzburg, Valentina Curella, Stefan Bittner, Frauke Zipp, Detlef Schuppan, Felix Luessi
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-06-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/17562864231170928

Similar Items

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
by: Sinah Engel, et al.
Published: (2022-04-01)

A Case of Progressive Multifocal Leukoencephalopathy in a Fumaric Acid-Treated Psoriasis Patient With Severe Lymphopenia Among Other Risk Factors
by: Sinah Engel, et al.
Published: (2021-08-01)

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
by: Sinah Engel, et al.
Published: (2021-04-01)

PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders
by: Sinah Engel, et al.
Published: (2020-01-01)

Elevated neurofilament light chain CSF/serum ratio indicates impaired CSF outflow in idiopathic intracranial hypertension
by: Sinah Engel, et al.
Published: (2023-01-01)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
by: Sinah Engel, et al.
Published: (2021-10-01)

Network alterations underlying anxiety symptoms in early multiple sclerosis
by: Erik Ellwardt, et al.
Published: (2022-05-01)

Predictors for insufficient SARS-CoV-2 vaccination response upon treatment in multiple sclerosisResearch in context
by: Muriel Schraad, et al.
Published: (2023-01-01)

Case Report: Balancing immune responses – multiple sclerosis disease exacerbation under BRAF/MEK treatment for malignant melanoma
by: Katrin Pape, et al.
Published: (2023-11-01)

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
by: Timo Uphaus, et al.
Published: (2021-10-01)

Comparative effectiveness of natalizumab ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
by: Katrin Pape, et al.
Published: (2022-12-01)

Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis
by: Annika Klumpp, MD, et al.
Published: (2022-10-01)

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders
by: Tobias Brummer, et al.
Published: (2021-08-01)

Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
by: Bettina Trinschek, et al.
Published: (2013-01-01)

Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario
by: Muriel Schraad, et al.
Published: (2024-03-01)

Endurance Exercise Attenuates Established Progressive Experimental Autoimmune Encephalomyelitis and Is Associated with an Amelioration of Innate Immune Responses in NOD Mice
by: Daniel Schiffmann, et al.
Published: (2023-10-01)

Multiple sclerosis therapy consensus group (MSTCG): answers to the discussion questions
by: Heinz Wiendl, et al.
Published: (2021-08-01)

Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
by: Martina Casari, et al.
Published: (2023-12-01)

Structural brain network characteristics can differentiate CIS from early RRMS
by: Muthuraman eMuthuraman, et al.
Published: (2016-02-01)

Characterization of 150 Wheat Cultivars by LC-MS-Based Label-Free Quantitative Proteomics Unravels Possibilities to Design Wheat Better for Baking Quality and Human Health
by: Muhammad Afzal, et al.
Published: (2021-02-01)

Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammation
by: Tobias Brummer, et al.
Published: (2023-11-01)

Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses
by: Steffen Pfeuffer, et al.
Published: (2022-09-01)

Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
by: Leonard Kaps, et al.
Published: (2020-09-01)

MRI pattern recognition in multiple sclerosis normal-appearing brain areas.
by: Martin Weygandt, et al.
Published: (2011-01-01)

Breeding from 1891 to 2010 did not increase the content of amylase/trypsin-inhibitors in wheat (Triticum aestivum)
by: Sabrina Geisslitz, et al.
Published: (2023-08-01)

The frequency of follicular T helper cells differs in acute and chronic neuroinflammation
by: Adalie Baniahmad, et al.
Published: (2020-11-01)

Investing in economic inclusion : leveraging the New Orleans BioDistrict to grow employment and human capital
by: Curella, Christine
Published: (2013)

Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis.
by: Bettina Trinschek, et al.
Published: (2013-01-01)

Multiomics Based Association Mapping in Wheat Reveals Genetic Architecture of Quality and Allergenic Related Proteins
by: Khaoula El Hassouni, et al.
Published: (2023-01-01)

Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
by: Coralie Chanvillard, et al.
Published: (2012-01-01)

CNS Pericytes Modulate Local T Cell Infiltration in EAE
by: Kathrin Koch, et al.
Published: (2022-10-01)

The impact of isolated lesions on white-matter fiber tracts in multiple sclerosis patients
by: Amgad Droby, et al.
Published: (2015-01-01)

Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
by: Liesa Regner-Nelke, et al.
Published: (2022-11-01)

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
by: Vinzenz Fleischer, et al.
Published: (2019-04-01)

Strict blood pressure control following thrombectomy is associated with neuronal injury and poor functional outcome
by: Marianne Hahn, et al.
Published: (2023-12-01)

Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
by: Dumitru Ciolac, et al.
Published: (2019-07-01)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
by: Simon Johannes Gairing, et al.
Published: (2023-04-01)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
by: Weinshenker, BG, et al.
Published: (1992)

Home infusions of natalizumab for people with multiple sclerosis: a pilot randomised crossover trial
by: Timothy J. Schultz, et al.
Published: (2021-08-01)

Functional characteristics of Th1, Th17, and ex-Th17 cells in EAE revealed by intravital two-photon microscopy
by: Julia Loos, et al.
Published: (2020-11-01)